Barely Significant
← all excerpts

Integration of personalised ultrasensitive ctDNA monitoring of patients with metastatic breast cancer to reduce imaging requirements.

Int J Cancer · 2025 · PMC11826139 · PMID 39692755

Europe PMCDOI
1
hedged sentence
0.0530
closest p · 1.1× alpha
0.0530
boldest claim

The sentences

borderline significantp = 0.053so close (0.05 < p ≤ 0.1)
A borderline significant difference in median PFS was observed between those with a ctDNA rise prior to PD and those with a rise at PD (13.4 months vs. 5.5 months, p = 0.053).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.